Swiss National Bank
PLSE icon

Swiss National Bank’s Pulse Biosciences PLSE Stock Holding History

Swiss National Bank’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$946K Sell
34,100
-5,000
-13% -$118K ﹤0.01% 2226
2026
Q1 		$844K Hold
39,100
– – ﹤0.01% 2198
2025
Q4 		$537K Hold
39,100
– – ﹤0.01% 2284
2025
Q3 		$692K Buy
39,100
+7,000
+22% +$111K ﹤0.01% 2261
2025
Q2 		$484K Buy
32,100
+8,300
+35% +$138K ﹤0.01% 2310
2025
Q1 		$383K Sell
23,800
-12,100
-34% -$226K ﹤0.01% 2374
2024
Q4 		$625K Hold
35,900
– – ﹤0.01% 2359
2024
Q3 		$630K Buy
+35,900
New +$612K ﹤0.01% 2376

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Swiss National Bank's PLSE Position: Q2 2026 in Review

Swiss National Bank reduced its Pulse Biosciences (PLSE) stake by 13% in Q2 2026, selling an estimated $118K and leaving 34,100 shares worth $946K. The position accounts for ﹤0.01% of the portfolio, ranked #2226.

Swiss National Bank first reported a position in PLSE in Q3 2024 and has held it in 8 quarters since. 105 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Swiss National Bank held 34,100 shares of Pulse Biosciences worth $946K as of Q2 2026.
  • Swiss National Bank sold 5,000 Pulse Biosciences shares in Q2 2026, an estimated $118K.
  • Pulse Biosciences made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #2226 holding.
  • Swiss National Bank first reported a position in Pulse Biosciences in Q3 2024 and has held it in 8 quarters since.
  • 105 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.